{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:38:51Z","timestamp":1792874331097,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016913","name":"MSDAVENIR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-23-IAHU-0011"],"award-info":[{"award-number":["ANR-23-IAHU-0011"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Frailty & Aging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tjfa.2026.100194","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:50:29Z","timestamp":1788526229000},"page":"100194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of plasma growth differentiation factor-15 with the frailty phenotype \u2013 Evidence from the COGFRAIL study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8801-0294","authenticated-orcid":false,"given":"Federico","family":"Bellelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Sanchez Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Angioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipe De Souto","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Sourdet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tjfa.2026.100194_bib0001","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","article-title":"Frailty Consensus: a call to action","volume":"14","author":"Morley","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"10.1016\/j.tjfa.2026.100194_bib0002","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"10.1016\/j.tjfa.2026.100194_bib0003","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1093\/ageing\/afab106","article-title":"Frailty trajectories in three longitudinal studies of aging: is the level or the rate of change more predictive of mortality?","volume":"50","author":"Bai","year":"2021","journal-title":"Age Ageing"},{"issue":"9","key":"10.1016\/j.tjfa.2026.100194_bib0004","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/jcmm.17725","article-title":"Overview of growth differentiation factor 15 in metabolic syndrome","volume":"27","author":"Asrih","year":"2023","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.tjfa.2026.100194_bib0005","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41591-023-02232-8","article-title":"Body composition and lung cancer-associated cachexia in TRACERx","volume":"29","author":"Al-Sawaf","year":"2023","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.tjfa.2026.100194_bib0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"24","key":"10.1016\/j.tjfa.2026.100194_bib0007","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjfa.2026.100194_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2025.112077","article-title":"The combination of GDF15, FGF21, sRAGE and NfL plasma levels can identify frailty in community-dwelling people across old age","volume":"226","author":"Conte","year":"2025","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.tjfa.2026.100194_bib0009","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.amjcard.2023.07.146","article-title":"Predictive biochemical model of frailty and mortality after acute myocardial infarction","volume":"205","author":"Pozo","year":"2023","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.tjfa.2026.100194_bib0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12603-022-1793-9","article-title":"Biomarkers of age-related frailty and frailty related to diseases: an exploratory, cross-sectional analysis from the MAPT study","volume":"26","author":"Angioni","year":"2022","journal-title":"J Nutr Health Aging"},{"issue":"25","key":"10.1016\/j.tjfa.2026.100194_bib0011","first-page":"685","article-title":"Genetic mechanisms, brain structures, and peripheral biomarkers mediate the relationship between physical frailty and neuropsychiatric disorders","volume":"82","author":"Gao","year":"2025","journal-title":"J Adv Res"},{"issue":"11","key":"10.1016\/j.tjfa.2026.100194_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13975","article-title":"Late-life plasma proteins associated with prevalent and incident frailty: a proteomic analysis","volume":"22","author":"Liu","year":"2023","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.tjfa.2026.100194_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.70182","article-title":"Associations between growth differentiating factor-15 and frailty in older adults from the MAPT study","volume":"17","author":"S\u00e1nchez-S\u00e1nchez","year":"2026","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.tjfa.2026.100194_bib0014","doi-asserted-by":"crossref","first-page":"160","DOI":"10.14283\/jfa.2020.57","article-title":"Cognitive function and amyloid marker in frail older adults: the COGFRAIL cohort study","volume":"10","author":"Sourdet","year":"2021","journal-title":"J Frailty Aging"},{"issue":"12","key":"10.1016\/j.tjfa.2026.100194_bib0015","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/gerona\/glac020","article-title":"Prospective associations of plasma growth differentiation factor 15 with physical performance and cognitive functions in older adults","volume":"77","author":"He","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.tjfa.2026.100194_bib0016","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.7457","article-title":"What matters in weight loss? An In-depth analysis of self-monitoring","volume":"19","author":"Painter","year":"2017","journal-title":"J Med Internet Res"},{"issue":"12","key":"10.1016\/j.tjfa.2026.100194_bib0018","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s43587-023-00522-x","article-title":"Reference centiles for intrinsic capacity throughout adulthood and their association with clinical outcomes: a cross-sectional analysis from the INSPIRE-T cohort","volume":"3","author":"Lu","year":"2023","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.tjfa.2026.100194_bib0019","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.tjfa.2026.100194_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.897097","article-title":"Growth differentiation factor-15 as a biomarker for sarcopenia in patients with chronic obstructive pulmonary disease","volume":"9","author":"Deng","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.tjfa.2026.100194_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.111115","article-title":"Growth differentiation factor-15 as a biomarker for sarcopenia in aging humans and mice","volume":"142","author":"Kim","year":"2020","journal-title":"Exp Gerontol"},{"issue":"4","key":"10.1016\/j.tjfa.2026.100194_bib0022","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcsm.13513","article-title":"GDF-15 is associated with sarcopenia and frailty in acutely admitted older medical patients","volume":"15","author":"Kamper","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.tjfa.2026.100194_bib0023","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/jcsm.12823","article-title":"Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study","volume":"12","author":"Alcazar","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.tjfa.2026.100194_bib0024","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/gerona\/glab201","article-title":"Associations between elevated growth differentiation factor-15 and sarcopenia among community-dwelling older adults","volume":"77","author":"Kim","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.tjfa.2026.100194_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mito.2019.10.005","article-title":"Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy","volume":"50","author":"Poulsen","year":"2020","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tjfa.2026.100194_bib0026","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fimmu.2020.00915","article-title":"GDF15 Plasma level is inversely associated with level of physical activity and correlates with markers of inflammation and muscle weakness","volume":"11","author":"Conte","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.tjfa.2026.100194_bib0027","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000356760","article-title":"Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review","volume":"60","author":"Ali","year":"2014","journal-title":"Gerontology"},{"issue":"1","key":"10.1016\/j.tjfa.2026.100194_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-14846-8","article-title":"Characterization of growth differentiation factor 15 (GDF15) as a neurotropic adipokine permeable to the brain","volume":"15","author":"Schmid","year":"2025","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.tjfa.2026.100194_bib0029","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.mad.2006.01.002","article-title":"Limits to deficit accumulation in elderly people","volume":"127","author":"Rockwood","year":"2006","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"10.1016\/j.tjfa.2026.100194_bib0030","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13132","article-title":"Plasma proteomic signature of the risk of developing mobility disability: a 9-year follow-up","volume":"19","author":"Osawa","year":"2020","journal-title":"Aging Cell"},{"issue":"13","key":"10.1016\/j.tjfa.2026.100194_bib0031","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1080\/14656566.2019.1622093","article-title":"Current pharmacotherapies for sarcopenia","volume":"20","author":"Hardee","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.tjfa.2026.100194_bib0032","first-page":"462","article-title":"The role of GDF-15 in heart failure patients with chronic kidney disease","volume":"35","author":"Benes","year":"2019","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.tjfa.2026.100194_bib0033","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000498959","article-title":"Association between plasma levels of growth differentiation Factor-15 and renal function in the elderly: korean frailty and aging cohort study","volume":"44","author":"Kim","year":"2019","journal-title":"Kidney Blood Press Res"}],"container-title":["The Journal of Frailty & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2260134126000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2260134126000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:29:15Z","timestamp":1792873755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2260134126000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2260134126000630"],"URL":"https:\/\/doi.org\/10.1016\/j.tjfa.2026.100194","relation":{},"ISSN":["2260-1341"],"issn-type":[{"value":"2260-1341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of plasma growth differentiation factor-15 with the frailty phenotype \u2013 Evidence from the COGFRAIL study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Frailty & Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjfa.2026.100194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100194"}}